{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T05:13:49Z","timestamp":1788498829064,"version":"build-2803163510"},"posted":{"date-parts":[[2026,9,4]]},"group-title":"In Review","reference-count":33,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,7,23]]},"abstract":"<title>Abstract<\/title>\n                <p>This study aimed to identify inflammation-related gene signatures in multiple myeloma (MM) and evaluate their clinical diagnostic relevance through an integrated bioinformatics approach combined with preliminary clinical validation. To achieve this, we harmonized transcriptomic data from the GSE80608 and GSE146649 cohorts to unearth a core signature of 22 inflammation-related differentially expressed genes (IRDEGs) associated with MM pathogenesis. Functional mapping revealed that these mediators converge on critical biological axes, most notably cytokine signaling and Th17 cell differentiation. Through protein-protein interaction (PPI) topology and consensus screening, we pinpointed a cluster of nine high-fidelity hub genes\u2014including SERPINE1, CD4, and HBEGF\u2014all of which demonstrated robust diagnostic efficacy with AUC values between 0.7 and 0.9. Beyond static expression, immune profiling identified a potent synergy between this genetic signature and a dysregulated microenvironment, specifically characterized by accelerated Th17 cell infiltration. Crucially, clinical validation in independent patient samples confirmed the systemic upregulation of HBEGF and canonical Th17 markers (IL\u221217A, ROR\u03b3t). In conclusion, our integrated bioinformatics analysis and preliminary clinical profiling demonstrate a notable co-upregulation of HBEGF and Th17-related markers (IL\u221217A, ROR\u03b3t) in MM patients. These observational findings suggest a correlation between HBEGF and the Th17 inflammatory microenvironment, providing preliminary clues for future biomarker research.<\/p>","DOI":"10.21203\/rs.3.rs-10457258\/v1","type":"posted-content","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T04:20:17Z","timestamp":1788495617000},"source":"Crossref","is-referenced-by-count":0,"title":["Integrated bioinformatics and clinical validation identify HBEGF and Th17 markers as potential biomarkers in Multiple Myeloma"],"prefix":"10.21203","author":[{"given":"Hui","family":"Zhang","sequence":"first","affiliation":[{"name":"Zhang Zhongjing School of Chinese Medicine, Nanyang Institute of Technology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruijuan","family":"Du","sequence":"additional","affiliation":[{"name":"Zhang Zhongjing School of Chinese Medicine, Nanyang Institute of Technology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Cheng","sequence":"additional","affiliation":[{"name":"Zhang Zhongjing School of Chinese Medicine, Nanyang Institute of Technology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LiFang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Zhang Zhongjing School of Chinese Medicine, Nanyang Institute of Technology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Bian","sequence":"additional","affiliation":[{"name":"Zhang Zhongjing School of Chinese Medicine, Nanyang Institute of Technology"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"issue":"3","key":"ref1","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24032938","article-title":"The Relationship between Serum miRNAs and Early Mortality in Multiple Myeloma Patients Treated with Bortezomib-Based Regimens","volume":"24","author":"Pu\u0142a A","year":"2023","unstructured":"Pu\u0142a A et al. The Relationship between Serum miRNAs and Early Mortality in Multiple Myeloma Patients Treated with Bortezomib-Based Regimens. Int J Mol Sci, 2023. 24(3).","journal-title":"Int J Mol Sci"},{"issue":"5","key":"ref2","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1021\/acs.jmedchem.0c01516","article-title":"A Decade of FDA-Approved Drugs (2010\u20132019): Trends and Future Directions","volume":"64","author":"Brown DG","year":"2021","unstructured":"Brown DG, Wobst HJ. A Decade of FDA-Approved Drugs (2010\u20132019): Trends and Future Directions. J Med Chem. 2021;64(5):2312\u201338.","journal-title":"J Med Chem"},{"issue":"6","key":"ref3","doi-asserted-by":"crossref","first-page":"871","DOI":"10.2169\/internalmedicine.7955-21","article-title":"AL-Kappa Primary Amyloidosis with Apolipoprotein A-IV Deposition","volume":"61","author":"Ishimitsu A","year":"2022","unstructured":"Ishimitsu A, et al. AL-Kappa Primary Amyloidosis with Apolipoprotein A-IV Deposition. Intern Med. 2022;61(6):871\u20136.","journal-title":"Intern Med"},{"issue":"3","key":"ref4","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1200\/JCO.21.02815","article-title":"Elotuzumab Plus Pomalidomide and Dexamethasone for Relapsed\/Refractory Multiple Myeloma: Final Overall Survival Analysis From the Randomized Phase II ELOQUENT-3 Trial","volume":"41","author":"Dimopoulos MA","year":"2023","unstructured":"Dimopoulos MA, et al. Elotuzumab Plus Pomalidomide and Dexamethasone for Relapsed\/Refractory Multiple Myeloma: Final Overall Survival Analysis From the Randomized Phase II ELOQUENT-3 Trial. J Clin Oncol. 2023;41(3):568\u201378.","journal-title":"J Clin Oncol"},{"issue":"3","key":"ref5","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.htct.2023.04.006","article-title":"Outcomes of patients after mobilization failure of hematopoietic stem cells for autologous stem cell transplantation","volume":"46","author":"Santinelli-Pestana DV","year":"2024","unstructured":"Santinelli-Pestana DV, et al. Outcomes of patients after mobilization failure of hematopoietic stem cells for autologous stem cell transplantation. Hematol Transfus Cell Ther. 2024;46(3):256\u201360.","journal-title":"Hematol Transfus Cell Ther"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.pbiomolbio.2025.01.001","article-title":"The regulatory role of integrin in gastric cancer tumor microenvironment and drug resistance","volume":"195","author":"Wu S","year":"2025","unstructured":"Wu S, et al. The regulatory role of integrin in gastric cancer tumor microenvironment and drug resistance. Prog Biophys Mol Biol. 2025;195:130\u20136.","journal-title":"Prog Biophys Mol Biol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1023177","DOI":"10.3389\/fonc.2022.1023177","article-title":"The role of IL-6\/JAK2\/STAT3 signaling pathway in cancers","volume":"12","author":"Huang B","year":"2022","unstructured":"Huang B, Lang X, Li X. The role of IL-6\/JAK2\/STAT3 signaling pathway in cancers. Front Oncol. 2022;12:1023177.","journal-title":"Front Oncol"},{"issue":"5","key":"ref8","first-page":"515e1","volume":"48","author":"Agarwal A","year":"2023","unstructured":"Agarwal A, Pandey SD, Khare A. Peripheral Tubercular Neuritis J Hand Surg Am. 2023;48(5):515e1. 515.e5.","journal-title":"Peripheral Tubercular Neuritis J Hand Surg Am"},{"issue":"5","key":"ref9","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1021\/acsptsci.3c00039","article-title":"Topical Administration of an Apoptosis Inducer Mitigates Bleomycin-Induced Skin Fibrosis","volume":"6","author":"Huda MN","year":"2023","unstructured":"Huda MN, et al. Topical Administration of an Apoptosis Inducer Mitigates Bleomycin-Induced Skin Fibrosis. ACS Pharmacol Transl Sci. 2023;6(5):829\u201341.","journal-title":"ACS Pharmacol Transl Sci"},{"issue":"6","key":"ref10","doi-asserted-by":"crossref","first-page":"e255","DOI":"10.1016\/S1470-2045(23)00159-6","article-title":"Prevention and management of adverse events during treatment with bispecific antibodies and CAR T cells in multiple myeloma: a consensus report of the European Myeloma Network","volume":"24","author":"Ludwig H","year":"2023","unstructured":"Ludwig H, et al. Prevention and management of adverse events during treatment with bispecific antibodies and CAR T cells in multiple myeloma: a consensus report of the European Myeloma Network. Lancet Oncol. 2023;24(6):e255\u201369.","journal-title":"Lancet Oncol"},{"issue":"14","key":"ref11","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21145002","article-title":"Cytokine-Mediated Dysregulation of Signaling Pathways in the Pathogenesis of Multiple Myeloma","volume":"21","author":"Akhtar S","year":"2020","unstructured":"Akhtar S et al. Cytokine-Mediated Dysregulation of Signaling Pathways in the Pathogenesis of Multiple Myeloma. Int J Mol Sci, 2020. 21(14).","journal-title":"Int J Mol Sci"},{"key":"ref12","author":"Vargas Guti\u00e9rrez DA","year":"2022","unstructured":"Vargas Guti\u00e9rrez DA et al. Monoclonal Gammopathy of Renal Significance with Progression to Multiple Myeloma in a Patient with ASIA-MO Syndrome. Case Rep Hematol, 2022. 2022: p. 8571536."},{"issue":"3","key":"ref13","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1002\/cam4.5135","article-title":"Aberrantly expressed long noncoding RNAs as potential prognostic biomarkers in newly diagnosed multiple myeloma: A systemic review and meta-analysis","volume":"12","author":"Qin J","year":"2023","unstructured":"Qin J, et al. Aberrantly expressed long noncoding RNAs as potential prognostic biomarkers in newly diagnosed multiple myeloma: A systemic review and meta-analysis. Cancer Med. 2023;12(3):2199\u2013218.","journal-title":"Cancer Med"},{"issue":"4","key":"ref14","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1172\/JCI129205","article-title":"Immunotherapy of multiple myeloma","volume":"130","author":"Minnie SA","year":"2020","unstructured":"Minnie SA, Hill GR. Immunotherapy of multiple myeloma. J Clin Invest. 2020;130(4):1565\u201375.","journal-title":"J Clin Invest"},{"issue":"4","key":"ref15","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/s41375-020-0734-z","article-title":"B-cell maturation antigen (BCMA) in multiple myeloma: rationale for targeting and current therapeutic approaches","volume":"34","author":"Shah N","year":"2020","unstructured":"Shah N, et al. B-cell maturation antigen (BCMA) in multiple myeloma: rationale for targeting and current therapeutic approaches. Leukemia. 2020;34(4):985\u20131005.","journal-title":"Leukemia"},{"key":"ref16","author":"Zhao J","year":"2023","unstructured":"Zhao J et al. Bispecific antibodies targeting BCMA, GPRC5D, and FcRH5 for multiple myeloma therapy: latest updates from ASCO 2023 Annual Meeting. J Hematol Oncol, 2023. 16(1): p. 92."},{"issue":"4","key":"ref17","doi-asserted-by":"crossref","first-page":"4167","DOI":"10.3892\/ol.2017.6723","article-title":"Network-based analysis of the molecular mechanisms of multiple myeloma and monoclonal gammopathy of undetermined significance","volume":"14","author":"Liu Z","year":"2017","unstructured":"Liu Z, et al. Network-based analysis of the molecular mechanisms of multiple myeloma and monoclonal gammopathy of undetermined significance. Oncol Lett. 2017;14(4):4167\u201375.","journal-title":"Oncol Lett"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"6999","DOI":"10.2147\/IJGM.S377321","article-title":"Bioinformatics Analysis of the Key Genes and Pathways in Multiple Myeloma","volume":"15","author":"Sheng X","year":"2022","unstructured":"Sheng X, et al. Bioinformatics Analysis of the Key Genes and Pathways in Multiple Myeloma. Int J Gen Med. 2022;15:6999\u20137016.","journal-title":"Int J Gen Med"},{"key":"ref19","author":"Stelzer G","year":"2016","unstructured":"Stelzer G et al. The GeneCards Suite: From Gene Data Mining to Disease Genome Sequence Analyses. Curr Protoc Bioinformatics, 2016. 54: p. 1.30.1\u20131.30.33."},{"issue":"12","key":"ref20","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1093\/bioinformatics\/btr260","article-title":"Molecular signatures database (MSigDB) 3.0","volume":"27","author":"Liberzon A","year":"2011","unstructured":"Liberzon A, et al. Molecular signatures database (MSigDB) 3.0. Bioinformatics. 2011;27(12):1739\u201340.","journal-title":"Bioinformatics"},{"issue":"6","key":"ref21","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1093\/bioinformatics\/bts034","article-title":"The sva package for removing batch effects and other unwanted variation in high-throughput experiments","volume":"28","author":"Leek JT","year":"2012","unstructured":"Leek JT, et al. The sva package for removing batch effects and other unwanted variation in high-throughput experiments. Bioinformatics. 2012;28(6):882\u20133.","journal-title":"Bioinformatics"},{"issue":"7","key":"ref22","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie ME","year":"2015","unstructured":"Ritchie ME, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47.","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"ref23","first-page":"383","article-title":"Principal Component Analysis (PCA)","volume":"99","author":"Ben Salem K","year":"2021","unstructured":"Ben Salem K, Ben Abdelaziz A. Principal Component Analysis (PCA). Tunis Med. 2021;99(4):383\u20139.","journal-title":"Tunis Med"},{"issue":"D1","key":"ref24","doi-asserted-by":"crossref","first-page":"D419","DOI":"10.1093\/nar\/gky1038","article-title":"PANTHER version 14: more genomes, a new PANTHER GO-slim and improvements in enrichment analysis tools","volume":"47","author":"Mi H","year":"2019","unstructured":"Mi H, et al. PANTHER version 14: more genomes, a new PANTHER GO-slim and improvements in enrichment analysis tools. Nucleic Acids Res. 2019;47(D1):D419\u201326.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"ref25","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/nar\/28.1.27","article-title":"KEGG: kyoto encyclopedia of genes and genomes","volume":"28","author":"Kanehisa M","year":"2000","unstructured":"Kanehisa M, Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000;28(1):27\u201330.","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"ref26","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters","volume":"16","author":"Yu G","year":"2012","unstructured":"Yu G, et al. clusterProfiler: an R package for comparing biological themes among gene clusters. Omics. 2012;16(5):284\u20137.","journal-title":"Omics"},{"issue":"D1","key":"ref27","doi-asserted-by":"crossref","first-page":"D607","DOI":"10.1093\/nar\/gky1131","article-title":"STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets","volume":"47","author":"Szklarczyk D","year":"2019","unstructured":"Szklarczyk D, et al. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2019;47(D1):D607\u201313.","journal-title":"Nucleic Acids Res"},{"issue":"Suppl 4","key":"ref28","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1186\/1752-0509-8-S4-S11","article-title":"cytoHubba: identifying hub objects and sub-networks from complex interactome","volume":"8","author":"Chin CH","year":"2014","unstructured":"Chin CH, et al. cytoHubba: identifying hub objects and sub-networks from complex interactome. BMC Syst Biol. 2014;8(Suppl 4):S11.","journal-title":"BMC Syst Biol"},{"key":"ref29","author":"Yang X","year":"2019","unstructured":"Yang X et al. Study on the Multitarget Mechanism and Key Active Ingredients of Herba Siegesbeckiae and Volatile Oil against Rheumatoid Arthritis Based on Network Pharmacology. Evid Based Complement Alternat Med, 2019. 2019: p. 8957245."},{"issue":"D1","key":"ref30","doi-asserted-by":"crossref","first-page":"D127","DOI":"10.1093\/nar\/gkz757","article-title":"miRDB: an online database for prediction of functional microRNA targets","volume":"48","author":"Chen Y","year":"2020","unstructured":"Chen Y, Wang X. miRDB: an online database for prediction of functional microRNA targets. Nucleic Acids Res. 2020;48(D1):D127\u201331.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"ref31","doi-asserted-by":"crossref","first-page":"D43","DOI":"10.1093\/nar\/gkw965","article-title":"ChIPBase v2.0: decoding transcriptional regulatory networks of non-coding RNAs and protein-coding genes from ChIP-seq data","volume":"45","author":"Zhou KR","year":"2017","unstructured":"Zhou KR, et al. ChIPBase v2.0: decoding transcriptional regulatory networks of non-coding RNAs and protein-coding genes from ChIP-seq data. Nucleic Acids Res. 2017;45(D1):D43\u201350.","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"ref32","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.gpb.2019.09.006","article-title":"hTFtarget: A Comprehensive Database for Regulations of Human Transcription Factors and Their Targets","volume":"18","author":"Zhang Q","year":"2020","unstructured":"Zhang Q, et al. hTFtarget: A Comprehensive Database for Regulations of Human Transcription Factors and Their Targets. Genomics Proteom Bioinf. 2020;18(2):120\u20138.","journal-title":"Genomics Proteom Bioinf"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"607622","DOI":"10.3389\/fonc.2020.607622","article-title":"Identification and Verification of Immune-Related Gene Prognostic Signature Based on ssGSEA for Osteosarcoma","volume":"10","author":"Xiao B","year":"2020","unstructured":"Xiao B, et al. Identification and Verification of Immune-Related Gene Prognostic Signature Based on ssGSEA for Osteosarcoma. Front Oncol. 2020;10:607622.","journal-title":"Front Oncol"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-10457258\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-10457258\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T04:20:21Z","timestamp":1788495621000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-10457258\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,4]]},"references-count":33,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-10457258\/v1","relation":{},"subject":[],"published":{"date-parts":[[2026,9,4]]},"subtype":"preprint"}}